Commercialization

All articles by Commercialization

Signs point to upturn in pharma commercialization M&A in 2024
Signs point to upturn in pharma commercialization M&A in 2024
Marc Iskowitz
November 27, 2023
10:41 am

Several factors are coming together to create the right conditions for a major upturn in dealmaking in the pharma commercialization sector.

Aurinia Pharmaceuticals shareholder calls for sale of company, citing disappointing rollout of Lypkynis
Aurinia Pharmaceuticals shareholder calls for sale of company, citing disappointing rollout of Lypkynis
Lecia Bushak
April 26, 2023
9:51 am

MKT Capital, a major shareholder of Aurinia, announced that it would withhold support for the company’s leaders, including the chairman and CEO.

Cingulate signs commercialization agreement with Indegene for ADHD drug
Cingulate signs commercialization agreement with Indegene for ADHD drug
Lecia Bushak
March 15, 2023
3:35 pm

Indegene will take over the commercialization reins for Cingulate’s oral ADHD medication CTx-1301 as it enters Phase III trials.

  • From Our Partners